Supplements for trying to conceive (TTC)
For couples trying to conceive — the supplement layer that has actual fertility evidence for each partner, the items that are simply prenatal-essential, and the supplements that need to stop before pregnancy could occur.
The TTC supplement stack — rationale by ingredient and partner
For the female partner: prenatal multivitamin (or equivalent) with methylfolate 800 µg + iodine 150 µg + choline (often gap-fill needed)
Start at least 3 months before conception attempts. Methylfolate 800 µg/day (5-MTHF — the bioactive form, particularly important for the ~30% of people with reduced MTHFR enzyme activity) is the most-evidenced pre-conception supplement: reduces neural tube defect risk by ~70%. Iodine 150 µg/day for fetal neurodevelopment. Choline 450 mg/day during TTC and pregnancy — most prenatal vitamins are inadequate in choline, so a separate 250–300 mg choline bitartrate may be needed.
For the female partner: vitamin D3 to 25-OH-D target 30–50 ng/mL
Vitamin D deficiency is associated with reduced fertility, longer time-to-conception, and worse IVF outcomes. Test and target rather than supplementing blindly. Most pregnancies will need 2,000–4,000 IU/day depending on baseline status, BMI, and sun exposure.
For the female partner: omega-3 DHA 200 mg/day minimum (often higher for EPA co-benefits)
DHA is essential for fetal brain development; deficiency in the mother during preconception and pregnancy is associated with reduced offspring neurocognitive outcomes. A 200 mg DHA minimum is standard prenatal guidance; many TTC and pregnant women benefit from higher combined EPA+DHA (1 g/day) for maternal cardiovascular and mood benefits.
For the female partner: CoQ10 ubiquinol 200–600 mg/day, particularly age 35+
Oocyte mitochondrial function declines with age and is a major driver of age-related fertility decline. CoQ10 supports mitochondrial function in oocytes during the 90-day maturation window. Small RCT signal in IVF cycles, particularly diminished ovarian reserve cohorts. Reasonable adjunct, especially for women 35+ or with prior diminished response to stimulation.
For the female partner with PCOS or ovulatory dysfunction: myo-inositol 2 g + folic acid 200 µg twice daily
Multiple RCTs in PCOS show improved ovulatory frequency and pregnancy rates with myo-inositol. Generally well-tolerated; pregnancy-safe. Combinations with D-chiro-inositol (40:1 myo:DCI ratio) may be optimal.
For the male partner: antioxidant + mitochondrial sperm-quality stack
Spermatogenesis takes 74 days; supplement at least 3 months before conception attempts. The MOXI trial and subsequent meta-analyses (Cochrane male-fertility supplements review) show modest improvements in pregnancy rates with combined antioxidant supplementation, with CoQ10, zinc, selenium, vitamin C, vitamin E, and L-carnitine as the most-evidenced components. CoQ10 ubiquinol 200–400 mg/day, zinc 15–22 mg with 1–2 mg copper, omega-3 1–2 g/day, methylfolate 400 µg/day, vitamin D to target. Brand "male fertility" combinations (FertilAid, Proxeed, etc.) compile this stack; individual ingredients work too.
For both partners: identify and address underlying conditions before assuming the supplement layer is rate-limiting
Thyroid function (TSH ideally <2.5 for TTC), iron status (low ferritin contributes to anovulation), vitamin D as above, B12 (particularly in vegan/vegetarian diet), and (for the male partner) varicocele on examination, prior medication exposures (testosterone in any form is acutely fertility-destroying), recent illness with fever, prolonged heat exposure of testes. Couples should have basic fertility evaluation if not conceiving after 12 months of regular timed intercourse (6 months if female partner is 35+, or sooner with known risk factors).
What to skip / what to stop before TTC
- Testosterone or any androgen supplement — STOP IMMEDIATELY — even modest "natural" testosterone-boosting products with significant androgenic effect can suppress spermatogenesis for months after cessation. This includes prescription testosterone replacement: discuss alternative protocols (HCG, clomiphene) with a reproductive endocrinologist.
- Tongkat ali, fadogia agrestis, "test boosters" — pre-conception androgen modulation is the wrong direction.
- Ashwagandha — STOP before any chance of pregnancy — uterine stimulant in tradition; pregnancy contraindicated; some thyroid effects that may complicate TTC.
- Berberine, alpha-lipoic acid (high dose), bitter melon, fenugreek (medicinal doses) — pregnancy-contraindicated or inadequate pregnancy safety data; not appropriate during TTC if pregnancy could occur.
- St. John's Wort — multiple pregnancy concerns; interacts with hormonal contraception (relevant during the TTC transition).
- High-dose vitamin A (retinol >10,000 IU/day) — teratogenic; check the labels on any "skin/beauty" formulations.
- Megadose vitamin E (above 400 IU/day) — pregnancy concerns at high doses.
- "Detox" cleansing programs and prolonged fasts — particularly disruptive to ovulation; do not start during TTC.
- Saw palmetto for male hair loss during TTC — 5-alpha-reductase inhibition has not been adequately studied for sperm/pregnancy effects; pause.
- Cannabis (THC) for both partners — reduced sperm parameters in men; pregnancy outcomes concern for women; stop before TTC.
- Anabolic steroids, SARMs, peptides marketed for performance — fertility-destroying in men; pregnancy-incompatible in women.
- Heavy alcohol intake (both partners) — reduced fertility in both partners; risks neurodevelopmental harm in any pregnancy.
- NSAIDs around ovulation (women) — chronic NSAID use can impair ovulation (luteinised unruptured follicle syndrome); avoid around ovulation window if attempting conception.
Sources
- Greenberg JA, et al. Folic acid supplementation and pregnancy: more than just neural tube defect prevention. Rev Obstet Gynecol. 2011;4(2):52–59. PMID: 22102928
- Practice Committee of the American Society for Reproductive Medicine. The clinical relevance of luteal phase deficiency: a committee opinion. Fertil Steril. 2015;103(4):e27–32. PMID: 25681860
- de Ligny W, et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2022;5(5):CD007411. PMID: 35506389
- Ben-Meir A, et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell. 2015;14(5):887–895. PMID: 26111777
- Unfer V, et al. Effects of myo-inositol in women with PCOS — a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012;28(7):509–515. PMID: 22296306
- Wallace TC. A comprehensive review of eggs, choline, and lutein on cognition across the life-span. J Am Coll Nutr. 2018;37(4):269–285. PMID: 29381440
- Steegers-Theunissen RP, et al. The periconceptional period, reproduction and long-term health of offspring: the importance of one-carbon metabolism. Hum Reprod Update. 2013;19(6):640–655. PMID: 23959022
- Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012;166(5):765–778. PMID: 22275473